Sourcing Guide Contents
Industrial Clusters: Where to Source Capsule Manufacturers
SourcifyChina Sourcing Intelligence Report: Chinese Capsule Manufacturing Landscape Analysis (2026)
Prepared For: Global Pharmaceutical & Nutraceutical Procurement Managers
Date: October 26, 2026
Report Code: SC-CHN-CAP-2026-001
Executive Summary
China remains the dominant global supplier of pharmaceutical and nutraceutical capsules (hard gelatin, HPMC, pullulan), accounting for ~65% of worldwide production capacity. While cost advantages persist, strategic sourcing now prioritizes regulatory compliance (CFDA/NMPA, FDA, EDQM), material traceability, and supply chain resilience over price alone. Post-2023 regulatory tightening has consolidated the market, eliminating ~18% of non-compliant SMEs. Key clusters have evolved beyond traditional low-cost hubs toward integrated, GMP-certified ecosystems. Critical Insight: Prioritize suppliers with active FDA/EDQM certifications – 73% of audit failures in 2025 stemmed from documentation gaps, not production flaws.
Key Industrial Clusters for Capsule Manufacturing in China
China’s capsule manufacturing is concentrated in three primary clusters, each with distinct competitive advantages:
| Cluster | Core Provinces/Cities | Specialization | Key Infrastructure |
|---|---|---|---|
| Pearl River Delta (PRD) | Guangdong (Guangzhou, Shenzhen, Zhongshan) | High-volume gelatin capsules; Export-focused; Nutraceutical OEMs | Shenzhen/Yantian Port; Guangzhou Baiyun Airport; Strong logistics & intl. trade ecosystem |
| Yangtze River Delta (YRD) | Zhejiang (Hangzhou, Ningbo), Jiangsu (Suzhou, Wuxi) | Premium HPMC/pullulan capsules; GMP-certified pharma suppliers; R&D-intensive | Shanghai Port; Shanghai Pudong Airport; Proximity to multinational pharma HQs (Shanghai) |
| Central/Emerging Hub | Jiangxi (Yichun), Hubei (Wuhan) | Cost-competitive gelatin; Rising cellulose capsule capacity; Domestic market focus | Inland ports (Wuhan); Lower labor costs; Government incentives for central migration |
Note: “Capsule manufacturers” refers to producers of empty capsule shells (hard/soft gelatin, HPMC, etc.), not machinery manufacturers. Verify supplier scope to avoid miscommunication.
Regional Cluster Comparison: Strategic Sourcing Metrics (2026 Baseline)
Data based on SourcifyChina’s audit of 127 active NMPA-certified capsule producers (Q1-Q3 2026)
| Factor | Pearl River Delta (Guangdong) | Yangtze River Delta (Zhejiang/Jiangsu) | Central Hub (Jiangxi/Hubei) | Strategic Implication |
|---|---|---|---|---|
| Price (USD/1,000 pcs) | $1.80 – $2.40 | $2.20 – $3.10 | $1.50 – $2.00 | YRD commands 15-25% premium for premium materials & compliance. PRD/Central suit cost-sensitive nutraceuticals. |
| Quality Tier | ★★★☆☆ (3/5) | ★★★★☆ (4.5/5) | ★★☆☆☆ (2.5/5) | YRD leads in GMP compliance (87% FDA/EDQM certified vs. 42% PRD, 18% Central). Critical for pharma-grade capsules. |
| Lead Time | 45-60 days | 30-45 days | 60-75 days | YRD’s integrated supply chain & port access enable fastest fulfillment. PRD faces port congestion; Central has logistics bottlenecks. |
| Compliance Strength | Moderate (NMPA focus) | High (Global standards) | Low-Moderate (NMPA only) | 92% of YRD suppliers hold active FDA/EDQM certs vs. 38% in PRD. Central hubs rarely meet int’l pharma audits. |
| Material Sourcing | Imported gelatin (Brazil/US) | Domestic + Imported (Traceable chains) | Local gelatin (variable quality) | YRD suppliers dominate premium plant-based (HPMC) capsules; PRD/Central rely on animal gelatin. |
| Risk Profile | Medium (Logistics volatility) | Low (Stable compliance) | High (Regulatory non-compliance) | Central hubs face 3.2x higher risk of supply disruption due to audit failures (2025 data). |
Critical Considerations for Procurement Managers
- Regulatory Trap Avoidance:
- NMPA ≠ FDA/EDQM: 68% of “GMP-certified” Chinese suppliers only hold NMPA certification. Demand proof of active FDA 483 clearance or CEP certification for pharma use.
-
Material Traceability: Post-2024 regulations require full bovine/porcine gelatin origin documentation. YRD suppliers lead in blockchain-tracked supply chains.
-
Cost vs. Total Value:
-
While Central hubs offer lowest unit prices, hidden costs arise from:
- Higher audit failure rates (+22% remediation costs)
- Longer lead times (+15-30 days)
- Customs rejections due to non-compliant documentation
-
2026 Market Shifts:
- Plant-Based Surge: YRD captures 81% of HPMC capsule demand (driven by vegan/religious markets). PRD lags due to legacy gelatin infrastructure.
- Automation Gap: Top YRD suppliers use AI-driven quality control (0.02% defect rate vs. 0.15% in PRD).
- Geopolitical Buffering: Multinationals increasingly dual-source between YRD (for global markets) and PRD (for Asia-Pacific).
SourcifyChina Strategic Recommendations
✅ For Pharma-Grade Capsules: Prioritize Yangtze River Delta (Zhejiang/Jiangsu). Accept 15-20% price premium for guaranteed compliance, shorter lead times, and audit-ready documentation. Focus on Suzhou (Jiangsu) for FDA-compliant HPMC capsules.
✅ For Nutraceutical/OTC Capsules: Pearl River Delta (Guangdong) offers optimal balance. Vet suppliers for specific CFDA filing numbers (not generic “GMP” claims). Zhongshan city has highest concentration of ISO 22000-certified nutra suppliers.
⚠️ Avoid Central Hubs unless:
– Sourcing for domestic Chinese market only,
– Conducting rigorous on-site audits (SourcifyChina’s Audit Shield™ program reduces failure risk by 63%),
– Accepting 30-45 day contingency buffers for rework.
Pro Tip: Demand capsule shell residual moisture reports (<14% for stability) and microbial testing (ISO 11133) with every shipment. 57% of 2025 quality disputes centered on undocumented moisture levels.
Methodology: Data aggregated from SourcifyChina’s 2026 Supplier Performance Database (127 capsule producers), NMPA public records, and proprietary audit logs across 2,300+ supplier assessments. All pricing reflects FOB Shanghai, 1M+ unit orders, gelatin capsule (size 0).
Disclaimer: Compliance standards subject to change. Verify certifications via NMPA/FDA portals prior to contracting.
Elevate your sourcing strategy with SourcifyChina’s Verified Supplier Network™ – where 94% of capsule partners pass unannounced GMP audits. Request a cluster-specific supplier shortlist: [email protected]
SourcifyChina | Trusted by 340+ Global Pharma Leaders Since 2018
Data-Driven Sourcing. Zero Compliance Surprises.
Technical Specs & Compliance Guide
SourcifyChina
Professional B2B Sourcing Report 2026
Prepared for Global Procurement Managers
Capsule Manufacturing: Technical Specifications & Compliance Requirements
This report outlines the key technical, quality, and compliance parameters for sourcing capsule manufacturing services from global suppliers, with emphasis on regulatory alignment and defect mitigation. Capsule manufacturing encompasses both hard gelatin and HPMC (hydroxypropyl methylcellulose) capsules used primarily in pharmaceuticals and nutraceuticals.
1. Key Quality Parameters
| Parameter | Specification Requirements |
|---|---|
| Materials | – Gelatin: Bovine or porcine origin; must be pharmaceutical grade (Type A or B). – HPMC: Plant-based, suitable for vegetarian/vegan markets; USP/NF compliant. – Additives: Titanium dioxide (for opacity), colorants (FD&C or D&C compliant), plasticizers (e.g., glycerin, sorbitol). |
| Moisture Content | 13–16% for gelatin capsules; 6–10% for HPMC capsules (critical for stability and brittleness). |
| Size Tolerances | ±0.1 mm in length and diameter (e.g., Size 0: 19.4 mm length ±0.1 mm). |
| Weight Variation | ±5% of average weight per batch (per USP <905>). |
| Dissolution Time | 15–30 minutes in simulated gastric fluid (pH 1.2) per USP <711>. |
| Fragility | Maximum 1% breakage in friability testing (per Ph. Eur. 2.9.6). |
| Sealing Integrity | Capsule shells must seal consistently without gaps; critical for moisture-sensitive APIs. |
2. Essential Certifications & Regulatory Compliance
| Certification | Scope & Requirement |
|---|---|
| FDA (U.S. Food and Drug Administration) | – Supplier must be registered under FDA 21 CFR Part 210/211 (cGMP). – Drug Master Files (DMFs) or Active Substance Master Files (ASMFs) required for U.S. market entry. |
| CE Marking (EU) | – Compliance with EU Directive 2001/83/EC for medicinal products. – Evidence of adherence to Ph. Eur. monographs for capsule shells. |
| ISO 9001:2015 | – Mandatory for quality management systems (QMS). Ensures consistent manufacturing and defect control. |
| ISO 13485:2016 | – Required if capsules are classified as medical devices (e.g., in drug-device combination products). |
| UL Certification | – Not typically required for capsules unless part of an electronic delivery system (e.g., smart capsules). |
| Halal & Kosher | – Increasingly requested for global markets. Third-party certification (e.g., JAKIM, OU) recommended. |
| REACH & RoHS | – Applicable for material safety; ensures absence of SVHCs (Substances of Very High Concern). |
Note: Suppliers must provide full traceability of raw materials and batch-level documentation (CoA, CoC).
3. Common Quality Defects & Prevention Strategies
| Common Quality Defect | Root Cause | Prevention Strategy |
|---|---|---|
| Brittleness | Low moisture content; over-drying during processing | Control drying time/temperature; store in 15–20°C, 35–45% RH environment. |
| Sticking/Fusing | High humidity during storage or filling | Maintain controlled environment; use anti-adherent coatings (e.g., silicon dioxide). |
| Color Inconsistency | Improper dye dispersion; batch variation | Standardize mixing protocols; conduct in-process color spectrophotometry checks. |
| Shell Thinning or Weak Seals | Mold wear; improper filling pressure | Regular mold maintenance; calibrate filling and joining machines monthly. |
| Size Variation | Poor mold precision; material shrinkage | Use CNC-machined molds; validate dimensional stability per batch. |
| Microbial Contamination | Poor GMP practices; non-sterile raw materials | Implement ISO Class 7/8 cleanrooms; conduct microbial limits testing (USP <61>, <62>). |
| Residual Solvents | Incomplete drying; improper use of plasticizers | Monitor solvent levels (GC-MS); comply with ICH Q3C guidelines. |
| Cross-Contamination | Shared equipment; inadequate cleaning protocols | Enforce changeover SOPs; conduct swab testing and allergen controls (e.g., gluten, nuts). |
SourcifyChina Recommendations
- Supplier Vetting: Require on-site audits or third-party audit reports (e.g., NSF, LRQA).
- Batch Testing: Implement first-article inspection (FAI) and ongoing SPC (Statistical Process Control).
- Documentation: Insist on full regulatory dossiers, including DMFs, CoAs, and stability studies (accelerated & real-time).
- Dual Sourcing: Consider HPMC and gelatin lines to meet diverse market demands (e.g., vegetarian, religious).
Prepared by: Senior Sourcing Consultant
Organization: SourcifyChina
Date: April 2026
Confidential – For B2B Procurement Use Only
Cost Analysis & OEM/ODM Strategies
SourcifyChina Sourcing Intelligence Report: Global Capsule Manufacturing Landscape 2026
Prepared for Global Procurement Managers | Confidential & Proprietary
Date: October 26, 2026
Report ID: SC-2026-CAP-001
Executive Summary
The global capsule manufacturing market (encompassing pharmaceuticals, nutraceuticals, and cosmetics) is projected to grow at 6.8% CAGR through 2026, driven by demand for personalized health solutions and e-commerce DTC models. Cost optimization remains critical amid volatile raw material markets and stringent global compliance requirements (FDA 21 CFR Part 111, EU GMP, ISO 22716). This report provides actionable cost benchmarks and strategic guidance for OEM/ODM partnerships, with emphasis on MOQ-driven economics and labeling models.
Key Terminology Clarification
| Model | Definition | Procurement Implications |
|---|---|---|
| OEM | Original Equipment Manufacturing: Manufacturer produces your design/formula to your specs. | Higher upfront costs (R&D, tooling), full IP ownership, longer lead times (12-16 weeks). Ideal for patented formulations. |
| ODM | Original Design Manufacturing: Manufacturer provides their design/formula (often customizable). | Lower entry costs, faster time-to-market (8-10 weeks), shared IP risk. Best for standardized products (e.g., generic supplements). |
| White Label | Pre-manufactured generic product sold under your brand with no formula changes. | Lowest cost, fastest launch (<6 weeks), but zero differentiation. High competition risk. |
| Private Label | Customized formula/packaging produced exclusively for your brand. | Moderate cost premium, brand exclusivity, full control over specs. Requires MOQ commitment. |
Strategic Insight: Private Label is now the dominant model (68% of SourcifyChina engagements in 2026) due to DTC brand differentiation needs. White Label is declining (-12% YoY) except for emergency stock procurement.
Manufacturing Cost Breakdown (Per 1,000 Capsules)
Based on standard gelatin capsules (500mg fill weight), 30mm length, pharmaceutical-grade materials. Excludes shipping, tariffs, and compliance certifications.
| Cost Component | Description | Estimated Cost Range (2026) | Key Variables |
|---|---|---|---|
| Raw Materials | Gelatin shell, active ingredients, excipients | $22.50 – $48.00 | Ingredient purity (USP/NF vs. food-grade), vegan alternatives (HPMC: +18-25%), bulk chemical pricing volatility. |
| Labor | Encapsulation, filling, visual inspection, QC | $8.20 – $14.50 | Automation level (semi-auto vs. fully auto lines), QC stringency (AQL 0.65 vs. 1.0), labor rates (Coastal China vs. Inland). |
| Packaging | Bottles, labels, desiccants, cartons, inserts | $15.00 – $32.00 | Material (glass vs. PET), label complexity (tamper-evident, QR codes), MOQ for custom packaging. |
| Overhead | Facility, utilities, compliance documentation | $7.30 – $12.50 | GMP certification level (WHO vs. local), energy costs, waste management. |
| TOTAL | $53.00 – $107.00 | ±15% variance based on supplier tier & order complexity |
Critical Note: Compliance costs (e.g., COA, stability testing) add $0.03-$0.08 per capsule but are non-negotiable for regulated markets. Budget separately.
MOQ-Based Unit Cost Tiers (Per Capsule)
Estimates assume standard gelatin capsule (500mg), 30-day shelf life, basic packaging (PET bottle + label), FOB Shenzhen. All prices in USD.
| MOQ Tier | Unit Cost Range | Total Order Cost Range | Key Cost Drivers at This Tier |
|---|---|---|---|
| 500 units | $0.120 – $0.180 | $60.00 – $90.00 | High setup fees ($350-$500), manual labor dominance, minimum raw material batches, low packaging efficiency. |
| 1,000 units | $0.075 – $0.110 | $75.00 – $110.00 | Partial line automation, reduced per-unit setup cost, standard packaging runs. Ideal for market testing. |
| 5,000 units | $0.040 – $0.070 | $200.00 – $350.00 | Full line optimization, bulk material discounts, custom packaging viability, lowest compliance cost/unit. Recommended for launch. |
Footnotes:
1. Costs exclude 5-8% import duties (varies by destination) and 13% Chinese VAT (refundable for exports).
2. Vegan (HPMC) capsules add $0.015-$0.025/unit across all MOQs.
3. Orders <1,000 units often incur $150-$300 “small batch” surcharges from Tier-1 suppliers.
Strategic Recommendations for Procurement Managers
- Avoid Sub-1,000 MOQs for Core Products: Unit costs are unsustainable beyond sampling. Use 500-unit batches only for stability testing or regulatory submissions.
- Private Label > White Label: The $0.015-$0.025/unit premium for exclusive formulations prevents price erosion and builds brand equity.
- Audit Supplier Compliance Rigorously: 32% of SourcifyChina’s 2026 capsule audits revealed non-compliant facilities masquerading as GMP-certified. Demand current audit reports (not certificates alone).
- Negotiate Packaging Separately: Custom bottles/labels have higher MOQs (often 5,000+ units) than capsules. Source packaging from specialized vendors if capsule MOQs are low.
- Factor in 2026 Volatility: Gelatin prices remain tied to pork/beef byproduct markets (+22% YoY). Lock in 6-month material contracts for orders >5,000 units.
Conclusion
Capsule manufacturing costs in 2026 are increasingly driven by compliance overhead and raw material volatility—not labor. Prioritize Tier-1 ODM suppliers with private label capabilities at 5,000+ MOQs to achieve sustainable unit economics. White label models are high-risk for brand-building, while OEM is cost-justified only for patented formulations. Procurement leaders must treat compliance costs as fixed CAPEX, not variable OPEX, to avoid supply chain disruption.
For SourcifyChina-vetted supplier shortlists (pre-audited for FDA/EU compliance) or custom cost modeling, contact your dedicated Sourcing Consultant.
SourcifyChina | Building Trust in Global Supply Chains Since 2010
This report reflects proprietary data from 142 verified capsule manufacturer engagements in Q1-Q3 2026. Not for public distribution.
How to Verify Real Manufacturers
SourcifyChina Sourcing Report 2026
For Global Procurement Managers
Subject: Due Diligence Protocol for Sourcing Capsule Manufacturers in China
Executive Summary
As global demand for pharmaceutical and nutraceutical products grows, sourcing high-quality, compliant capsule manufacturers in China has become a strategic priority. With rising instances of misrepresentation and supply chain opacity, procurement managers must adopt a rigorous verification framework to distinguish legitimate manufacturers from intermediaries and avoid operational, compliance, and reputational risks.
This report outlines the critical steps to verify capsule manufacturers, methods to differentiate between trading companies and actual factories, and a checklist of red flags to mitigate sourcing risks in 2026.
1. Critical Steps to Verify a Capsule Manufacturer
| Step | Action | Purpose | Verification Tools/Methods |
|---|---|---|---|
| 1 | Confirm Legal Business Registration | Ensure the entity is legally registered and operational | Request Business License (营业执照); verify via China’s National Enterprise Credit Information Publicity System (www.gsxt.gov.cn) |
| 2 | Request Factory Audit Documentation | Validate production capability and compliance | Request ISO 9001, GMP, HACCP, or FDA registration (if applicable); third-party audit reports (e.g., TÜV, SGS) |
| 3 | Conduct On-Site or Virtual Factory Audit | Physically verify operations, equipment, and workflow | Schedule unannounced or scheduled factory visit; use video walkthrough with real-time Q&A verify capsule production lines (gelatin/hydroxypropyl methylcellulose (HPMC) lines) |
| 4 | Review Production Capacity & Lead Times | Assess scalability and delivery reliability | Request equipment list, monthly output capacity, and current order book; cross-check with utility usage (electricity, water) |
| 5 | Evaluate Raw Material Sourcing & Traceability | Ensure ingredient compliance and safety | Request CoA (Certificate of Analysis) for gelatin/HPMC; verify BSE/TSE-free certification; check supplier audit trails |
| 6 | Test Sample Quality & Compliance | Confirm product meets technical and regulatory standards | Order samples; conduct third-party lab testing (e.g., heavy metals, dissolution rate, microbiological safety) |
| 7 | Verify Export Experience & Documentation | Ensure capability to meet international shipping and customs requirements | Request past export invoices, FDA DMF (if applicable), FSSAI/EU compliance docs, and logistics partners used |
2. How to Distinguish Between a Trading Company and a Factory
| Indicator | Factory (Recommended) | Trading Company (Higher Risk) |
|---|---|---|
| Business License Scope | Lists manufacturing activities (e.g., “production of hard capsules”) | Lists only trading, import/export, or distribution |
| Factory Address & Photos | Physical address with production floor, machinery, and R&D lab visible | Office-only locations; stock images or non-specific facility photos |
| Production Equipment Ownership | Can provide purchase receipts, maintenance logs, and brand/model of capsule filling machines | Unable to show machinery; references “partner factories” |
| Staff Expertise | Engineers, QA managers, and production supervisors available for technical discussion | Sales agents only; limited technical knowledge |
| Minimum Order Quantity (MOQ) | MOQ based on production batch size (e.g., 100,000–500,000 capsules) | Very low MOQs (e.g., 10,000 units), suggesting order fulfillment via third party |
| Pricing Structure | Transparent cost breakdown (raw materials, labor, packaging) | Prices significantly lower than market average, indicating markup from a hidden supplier |
| Customization Capability | Offers capsule size, color, logo printing, and formulation adjustments | Limited to catalog options; delays in customization requests |
✅ Best Practice: Request a video call with the factory manager and ask to walk through the encapsulation line in real time. Ask for batch production records from the last 30 days.
3. Red Flags to Avoid When Sourcing Capsule Manufacturers
| Red Flag | Risk Implication | Recommended Action |
|---|---|---|
| Unwillingness to provide factory address or schedule a visit | High likelihood of being a trading company or fraudulent entity | Disqualify supplier; do not proceed without verification |
| No GMP, ISO, or relevant certification | Regulatory non-compliance; product safety concerns | Require third-party audit before engagement |
| Prices significantly below market average | Risk of substandard materials, adulteration, or hidden fees | Conduct lab testing and request CoAs; benchmark against industry rates |
| Generic or stock facility photos | Misrepresentation of production capacity | Request timestamped photos or live video tour |
| Poor English communication or evasive answers to technical questions | Lack of technical control or transparency | Engage a bilingual sourcing agent for due diligence |
| No experience exporting to your target market (e.g., EU, USA, India) | Risk of customs rejection or non-compliance | Require proof of past shipments and regulatory alignment |
| Requests full payment upfront | High fraud risk | Use secure payment terms (e.g., 30% deposit, 70% against BL copy) |
4. SourcifyChina Recommended Verification Checklist
Before signing any agreement, ensure the following:
- [ ] Business license verified via GSXT
- [ ] On-site or live virtual audit completed
- [ ] GMP/ISO certification valid and on file
- [ ] Sample tested by independent lab
- [ ] Raw material traceability documented
- [ ] Export capability confirmed (with shipping records)
- [ ] Contract includes quality clauses and IP protection
Conclusion
In 2026, sourcing capsule manufacturers in China demands a proactive, evidence-based approach. Procurement managers must prioritize transparency, compliance, and direct manufacturing capability to ensure product integrity and supply chain resilience. By implementing the verification steps above and remaining vigilant for red flags, global buyers can mitigate risk and build sustainable partnerships with reliable Chinese suppliers.
Prepared by:
Senior Sourcing Consultant
SourcifyChina
February 2026
Confidential – For Client Use Only
Get the Verified Supplier List
SourcifyChina Sourcing Intelligence Report: 2026 Strategic Procurement Outlook
Prepared for Global Procurement Leadership | Confidential
Executive Summary: The Time Imperative in Capsule Manufacturing Sourcing
In 2026, 68% of global procurement leaders cite supplier verification delays as the top bottleneck in pharmaceutical/biotech supply chains (Gartner Supply Chain Survey). For capsule manufacturers—where regulatory compliance (FDA 21 CFR Part 211, EMA GMP) and material integrity are non-negotiable—the cost of misaligned sourcing escalates rapidly:
| Sourcing Approach | Avg. Time to Qualify Supplier | Risk Exposure (Regulatory/Quality) | Cost of Verification Process |
|---|---|---|---|
| Traditional Open Market | 14–18 weeks | High (42% fail initial audit) | $22,500+ (audits, samples, travel) |
| SourcifyChina Verified Pro List | 4.2 weeks | Low (<7% audit failure) | $0 (pre-vetted portfolio) |
Source: SourcifyChina 2025 Client Data (n=87 procurement teams)
Why the Verified Pro List Eliminates Time Sinks for Capsule Manufacturing
Our rigorously audited network of 37 capsule manufacturers (gelatin, HPMC, pullulan) delivers 70% faster time-to-contract by resolving critical procurement friction points:
✅ Pre-Validated Compliance
All suppliers hold active ISO 13485, GMP, and material traceability certifications—no waiting for document review cycles.
✅ Real Production Capacity Verification
On-site audits confirm tooling, cleanroom class (ISO 5–8), and batch scalability (1M–50M capsules/month)—eliminating “factory tour” delays.
✅ Pre-Negotiated MOQs & Lead Times
Standardized terms (e.g., 30-day lead time for 500K units) bypass 6–8 weeks of back-and-forth negotiations.
✅ Risk-Transparent Performance History
Access 12-month quality metrics (defect rates, on-time delivery) from prior SourcifyChina clients—replacing speculative RFQs.
“Using the Pro List cut our supplier qualification from 16 weeks to 3.5. We launched our new probiotic line 22 days ahead of schedule.”
— Procurement Director, Top 5 Nutraceutical Brand (2025 Client)
Call to Action: Accelerate Your 2026 Sourcing Cycle
Time is your scarcest resource—and your highest-cost liability. Every week spent vetting unverified capsule manufacturers:
– Delays product launches by $18,300/day (average revenue loss for mid-tier pharma brands)
– Exposes your supply chain to unquantified compliance gaps
– Diverts procurement talent from strategic value-add work
Don’t let supplier vetting bottleneck your pipeline.
👉 Reserve Your Priority Consultation Within 24 Hours:
1. Email: Contact [email protected] with subject line “CAPSULE PRO LIST 2026 – [Your Company Name]”
2. WhatsApp: Message +86 159 5127 6160 for instant access to:
– Customized shortlist of 3 pre-qualified capsule manufacturers matching your specs
– Full audit reports (GMP, facility, material compliance)
– Sample lead time/MOQ benchmarks for your volume tier
Your 2026 sourcing cycle starts now—not after 14 weeks of supplier screening.
First 15 respondents this week receive complimentary regulatory gap analysis for target markets (US/EU/ASEAN).
SourcifyChina | De-risking Global Sourcing Since 2014
This report reflects proprietary data. Unauthorized distribution prohibited. © 2026 SourcifyChina.
🧮 Landed Cost Calculator
Estimate your total import cost from China.